AnaptysBio, Inc. (ANAB)
57.68
+0.95
(+1.67%)
USD |
NASDAQ |
Apr 02, 16:00
57.92
+0.24
(+0.42%)
After-Hours: 20:00
AnaptysBio EPS Diluted (Quarterly) : 1.583 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 0.2025 |
| Nektar Therapeutics | -1.778 |
| Rigel Pharmaceuticals, Inc. | 13.54 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
| Adaptive Biotechnologies Corp. | -0.0887 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 49.61M |
| Revenue (Quarterly) | 108.25M |
| Total Expenses (Quarterly) | 58.64M |
| Enterprise Value | 1.637B |
| Gross Profit Margin (Quarterly) | 99.44% |
| Profit Margin (Quarterly) | 45.83% |
| Earnings Yield | -0.88% |
| Operating Earnings Yield | 2.72% |
| Normalized Earnings Yield | -0.8839 |